BeOne Medicines Ltd. (ONC)
361.03
+1.06
(+0.29%)
USD |
NASDAQ |
Sep 25, 09:33
BeOne Medicines Cash and Short Term Investments (Quarterly) : 5.259B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.259B |
| March 31, 2026 | 4.833B |
| December 31, 2025 | 4.589B |
| September 30, 2025 | 4.090B |
| June 30, 2025 | 2.772B |
| March 31, 2025 | 2.528B |
| December 31, 2024 | 2.637B |
| September 30, 2024 | 2.711B |
| June 30, 2024 | 2.616B |
| March 31, 2024 | 2.805B |
| December 31, 2023 | 3.186B |
| September 30, 2023 | 3.186B |
| June 30, 2023 | 3.526B |
| March 31, 2023 | 3.833B |
| December 31, 2022 | 4.535B |
| September 30, 2022 | 5.069B |
| June 30, 2022 | 5.704B |
| March 31, 2022 | 6.245B |
| December 31, 2021 | 6.618B |
| September 30, 2021 | 3.917B |
| June 30, 2021 | 4.382B |
| March 31, 2021 | 4.813B |
| Date | Value |
|---|---|
| December 31, 2020 | 4.651B |
| September 30, 2020 | 4.719B |
| June 30, 2020 | 3.153B |
| March 31, 2020 | 3.374B |
| December 31, 2019 | 983.03M |
| September 30, 2019 | 1.246B |
| June 30, 2019 | 1.552B |
| March 31, 2019 | 1.629B |
| December 31, 2018 | 1.796B |
| September 30, 2018 | 2.048B |
| June 30, 2018 | 1.401B |
| March 31, 2018 | 1.481B |
| December 31, 2017 | 837.52M |
| September 30, 2017 | 757.44M |
| June 30, 2017 | 407.43M |
| March 31, 2017 | 327.48M |
| December 31, 2016 | 368.17M |
| September 30, 2016 | 203.62M |
| June 30, 2016 | 226.62M |
| March 31, 2016 | 247.23M |
| December 31, 2015 | 100.49M |
| September 30, 2015 | 121.34M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Basilea Pharmaceutica AG | -- |
| Santhera Pharmaceuticals Holding AG | -- |
| AC Immune SA | 93.42M |
| CRISPR Therapeutics AG | 2.365B |
| Idorsia Ltd. | 109.95M |